Extracellular vesicle-associated lncRNA LYPLAL1-DT mediates endothelial-cancer cell communication, promoting small cell lung cancer progression

Abstract

Aim: Representing about 15% of lung cancers, small cell lung cancer (SCLC) is an extremely aggressive disease characterized by rapid growth and early spread, leading to dismal clinical outcomes. In this study, we aimed to investigate the dual roles of exosomal long non-coding RNA (lncRNA) LYPLAL1-DT (LYPLAL1 divergent transcript) in both tumor cells and vascular endothelial cells.

Methods: The circulating levels of LYPLAL1-DT were measured using real-time polymerase chain reaction in 13 SCLC patients and 21 normal controls. Exosomes from the supernatant of cell culture medium or serum were extracted through ultracentrifugation and dyed with PKH67 green fluorescent cell linker to identify internalization. Migration and invasion assay, colony formation, Cell Counting Kit-8 (CCK-8), and tube formation assays were used to assess the malignant effects of extracellular RNAs (exRNAs) LYPLAL1-DT in exosomes.

Results: Exosomal LYPLAL1-DT is upregulated in SCLC patients and plays a dual role in promoting tumor cell aggressiveness and enhancing pro-angiogenic behavior in endothelial cells, thereby accelerating SCLC progression. Mechanistically, LYPLAL1-DT functions as a competing endogenous RNA, exerting its effects through the miR-204-5p/profilin-2, miR-204-5p/B-cell lymphoma 2 and miR-204-5p/sirtuin 1 regulatory axes. These pathways underscore the pleiotropic effects of exosomal LYPLAL1-DT and underscore its value as a promising therapeutic target.

Conclusion: In the current study, we investigated the bidirectional communication mediated by exRNA LYPLAL1-DT between SCLC and endothelial cells, while also exploring its potential regulatory targets. This research provides a potential circulating biomarker for the diagnosis, prognosis, and treatment of SCLC.

Keywords

LYPLAL1-DT / exosome / endothelial cells / PFN2 / BCL2 / SIRT1 / SCLC

References

[1] Wang Q,Colarossi C.SCLC: epidemiology, risk factors, genetic susceptibility, molecular pathology, screening, and early detection.J Thorac Oncol2023;18:31-46 PMCID:PMC10797993

[2] Sen T,Chakraborty S.Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer.Nat Rev Clin Oncol2024;21:610-27 PMCID:PMC11875021

[3] Amolegbe SM,Ambrosi A.Extracellular RNA communication: a decade of NIH common fund support illuminates exRNA biology.J Extracell Vesicles2025;14:e70016 PMCID:PMC11735951

[4] Kim S,Jeon YJ.Extracellular RNA: emerging roles in cancer cell communication and biomarkers.Cancer Lett2020;495:33-40

[5] Hsu CY,Bansal P.MicroRNA-enriched exosome as dazzling dancer between cancer and immune cells.J Physiol Biochem2024;80:811-29

[6] Chen H,Xing G.Exosome tropism and various pathways in lung cancer metastasis.Front Immunol2025;16:1517495 PMCID:PMC11868168

[7] Yang L,Li Y.Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma.Mol Cancer2019;18:78 PMCID:PMC6446409

[8] Deng M,Liu S,Xiao H.Exosome-transmitted LINC00461 promotes multiple myeloma cell proliferation and suppresses apoptosis by modulating microRNA/BCL-2 expression.Cytotherapy2019;21:96-106

[9] Xue M,Xiang A.Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1.Mol Cancer2017;16:143 PMCID:PMC5574139

[10] de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth.Cancer Cell2023;41:374-403

[11] Al-Nedawi K,Micallef J.Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells.Nat Cell Biol2008;10:619-24

[12] Kucharzewska P,Welch JE.Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.Proc Natl Acad Sci U S A2013;110:7312-7 PMCID:PMC3645587

[13] Hsu YL,Chang WA.Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1.Oncogene2017;36:4929-42

[14] Zhu X,Cui J.LncRNA LYPLAL1-DT screening from type 2 diabetes with macrovascular complication contributes protective effects on human umbilical vein endothelial cells via regulating the miR-204-5p/SIRT1 axis.Cell Death Discov2022;8:245 PMCID:PMC9068612

[15] Li S,Zhang X.ELAVL4 promotes the tumorigenesis of small cell lung cancer by stabilizing LncRNA LYPLAL1-DT and enhancing profilin 2 activation.FASEB J2023;37:e23170

[16] Li S,Li Z.Overcoming multi-drug resistance in SCLC: a synergistic approach with venetoclax and hydroxychloroquine targeting the lncRNA LYPLAL1-DT/BCL2/BECN1 pathway.Mol Cancer2024;23:243 PMCID:PMC11526623

[17] Baine MK,Lai WV.SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: a comprehensive immunohistochemical and histopathologic characterization.J Thorac Oncol2020;15:1823-35 PMCID:PMC8362797

[18] Kim MJ,Han GY,Ahn C.Profilin 2 promotes migration, invasion, and stemness of HT29 human colorectal cancer stem cells.Biosci Biotechnol Biochem2015;79:1438-46

[19] Yan J,Gao Y.MicroRNA-30a-5p suppresses epithelial-mesenchymal transition by targeting profilin-2 in high invasive non-small cell lung cancer cell lines.Oncol Rep2017;37:3146-54

[20] Cao Q,Wu Y.Profilin 2 promotes growth, metastasis, and angiogenesis of small cell lung cancer through cancer-derived exosomes.Aging2020;12:25981-99 PMCID:PMC7803489

[21] Kaloni D,Strasser A.BCL-2 protein family: attractive targets for cancer therapy.Apoptosis2023;28:20-38 PMCID:PMC9950219

[22] Delbridge AR,Strasser A.Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies.Nat Rev Cancer2016;16:99-109

[23] Wu QJ,Chen HH.The sirtuin family in health and disease.Signal Transduct Target Ther2022;7:402 PMCID:PMC9797940

[24] Alves-Fernandes DK.The role of SIRT1 on DNA damage response and epigenetic alterations in cancer.Int J Mol Sci2019;20:3153 PMCID:PMC6651129

[25] Boelens MC,Nabet BY.Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways.Cell2014;159:499-513 PMCID:PMC4283810

[26] Zhou W,Min Y.Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis.Cancer Cell2014;25:501-15 PMCID:PMC4016197

[27] Liu T,Fang P.Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma.J Hematol Oncol2022;15:141 PMCID:PMC9548164

[28] Li Z,Zhang Y.Exosome-based Ldlr gene therapy for familial hypercholesterolemia in a mouse model.Theranostics2021;11:2953-65 PMCID:PMC7806494

[29] Dembélé P,Martin DK.Microtumor spheroids provide a model for studying molecules involved in vascular organization: an illustrative study for VE-cadherin.Anticancer Res2022;42:4689-700

[30] Kelley M,Purkey L.Endothelial cell tube formation assay: an in vitro model for angiogenesis.Methods Mol Biol2022;2475:187-96

[31] Wüstehube J,Liebler SS.Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling.Proc Natl Acad Sci U S A2010;107:12640-5 PMCID:PMC2906569

[32] Li Y,Bao C.Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis.Cell Res2015;25:981-4 PMCID:PMC4528056

[33] Welsh JA, Goberdhan DCI, O’Driscoll L, et al; MISEV Consortium. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13:e12404. PMCID:PMC10850029

[34] Matei I,Lyden D.Unshielding exosomal RNA unleashes tumor growth and metastasis.Cell2017;170:223-5

[35] Nabet BY,Shabason JE.Exosome RNA unshielding couples stromal activation to pattern recognition receptor signaling in cancer.Cell2017;170:352-66.e13 PMCID:PMC6611169

[36] Lunavat TR,Einarsdottir BO.BRAF(V600) inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells.Proc Natl Acad Sci U S A2017;114:E5930-9 PMCID:PMC5530690

[37] Redzic JS,van der Vos KE.Extracellular RNA mediates and marks cancer progression.Semin Cancer Biol2014;28:14-23 PMCID:PMC4162815

[38] Hu W,Bi ZY.Comprehensive landscape of extracellular vesicle-derived RNAs in cancer initiation, progression, metastasis and cancer immunology.Mol Cancer2020;19:102 PMCID:PMC7273667

[39] Jiang X,Deng X.The role of microenvironment in tumor angiogenesis.J Exp Clin Cancer Res2020;39:204 PMCID:PMC7526376

[40] Liu ZL,Zheng LL,Shi L.Angiogenic signaling pathways and anti-angiogenic therapy for cancer.Signal Transduct Target Ther2023;8:198 PMCID:PMC10175505

[41] Li H.Exosomes from BM-MSCs increase the population of CSCs via transfer of miR-142-3p.Br J Cancer2018;119:744-55 PMCID:PMC6173771

[42] Ren W,Yang C.Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery.J Exp Clin Cancer Res2019;38:62 PMCID:PMC6367822

[43] Goveia J,Taverna F.An integrated gene expression landscape profiling approach to identify lung tumor endothelial cell heterogeneity and angiogenic Candidates.Cancer Cell2020;37:21-36.e13

[44] Lee TH,Audemard E,Meehan B.Oncogenic ras-driven cancer cell vesiculation leads to emission of double-stranded DNA capable of interacting with target cells.Biochem Biophys Res Commun2014;451:295-301

[45] Takasugi M,Takahashi A,Watanabe S.Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2.Nat Commun2017;8:15729 PMCID:PMC5467215

[46] Imjeti NS,Egea-Jimenez AL.Syntenin mediates SRC function in exosomal cell-to-cell communication.Proc Natl Acad Sci U S A2017;114:12495-500 PMCID:PMC5703317

[47] Wu D,Eshraghian EA,Li Z.Extracellular RNA as a kind of communication molecule and emerging cancer biomarker.Front Oncol2022;12:960072 PMCID:PMC9714358

[48] Han QF,Hu KS.Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer.Mol Cancer2022;21:207 PMCID:PMC9623991

[49] Mouneimne G,Selfors LM.Differential remodeling of actin cytoskeleton architecture by profilin isoforms leads to distinct effects on cell migration and invasion.Cancer Cell2012;22:615-30 PMCID:PMC3500527

[50] Toyota N,Tajima Y.Profilin 2 isoform expression is associated with lung metastasis of colorectal cancer according to a comprehensive gene expression study using a mouse model.Oncol Lett2024;28:381 PMCID:PMC11209866

[51] Lugano R,Dimberg A.Tumor angiogenesis: causes, consequences, challenges and opportunities.Cell Mol Life Sci2020;77:1745-70 PMCID:PMC7190605

[52] Pan X,Dong L.Tumour vasculature at single-cell resolution.Nature2024;632:429-36

[53] Kopp F.Functional classification and experimental dissection of long noncoding RNAs.Cell2018;172:393-407 PMCID:PMC5978744

[54] Zhao H,Yu L.Comprehensive landscape of epigenetic-dysregulated lncRNAs reveals a profound role of enhancers in carcinogenesis in BC subtypes.Mol Ther Nucleic Acids2021;23:667-81 PMCID:PMC7851425